PreComb Therapeutics
Technology that generates 3D tumour twins that mimic the behaviour and characteristics of the original tumour
PreComb Therapeutics has raised €1.3M across 1 funding round from 3 investors, most recently a Seed round in Oct 2022. Based in Hombrechtikon, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Hombrechtikon, Switzerlandwww.precomb.com ↗
Total raised
€1.3M
€1,331,013
Funding rounds
1
Investors
3
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearPreComb Therapeutics — funding by year — interactive chart.
Data table
| PreComb Therapeutics — funding by year | |
|---|---|
| 2022 | €1.3M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-04 | Seed | €1.3M | Kinled Holding,LongeVC,Private Investors | View deal → |
Investors
3Related news
- CHF1.3 million to bring precision medicine to all cancer patientsstartupticker.ch · 2022-10
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData